EDUCATION
Missing Data in Randomized Controlled Trials and Systematic Reviews: Top 5 Tips You Must Know .
Missing data is far more common in RCTs and systematic reviews than most readers realize, and its impact on treatment estimates can be substantial. Dropouts, missed visits, and unmeasured outcomes weaken the balance created by randomization, reduce power, and can bias results in either direction. Because missingness is often not random, trialists must understand what the data type is and choose appropriate methods—such as multiple imputation, maximum likelihood, or structured sensitivity analyses—to test the robustness of findings. Systematic reviews face similar challenges and should assess how each study handled missingness, evaluate risk of bias, and explore best- and worst-case assumptions. Ultimately, the most effective strategy remains prevention through thoughtful trial design and proactive follow-up.
Already have an account? Log in
Unlock the Full original article
You have access to 4 more FREE articles this month.
Click below to unlock and view this original article
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
